Human umbilical cord mesenchymal stem cell-derived secretome
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human umbilical cord mesenchymal stem cell-derived secretome, covering 2024-10-08 to 2024-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial [Phase 1]